Free Webinar: Microbiome Analysis at Strain-Level: Study Design for Pre-Clinical and Clinical Drug Development

April 3, 2019 | 1:00 pm CDT   View the Replay 

About the Conference

Arrowhead Publishers is pleased to announce the return of its 6th Annual Translational Microbiome Conference to Boston on April 21-23, 2020, taking place at the Westin Copley Place. As the official conference of The Microbiome Coalition (TMBC), the Arrowhead Translational Microbiome Conference was the first microbiome conference in the field to focus exclusively on the hurdles and challenges to commercial success in the space.


Once again, the conference will bring together the leading microbiome companies working to successfully commercialize microbiome-based diagnostics, therapeutics, adjunct therapies and direct-to-consumer services and products across a range of therapeutic areas, from gut to skin and beyond. Expanding on this core focus year on year, we continue to offer informative, hands-on workshops, panels sponsored and directed by industry to focus on your concerns and tightly curated content that goes beyond the usual infomercials to provide tangible and useful insights to how your peers are addressing their commercial approach to the space.


Entering its 6th year in 2020, the meeting will continue to focus and build on the challenges and hurdles that companies working in the microbiome space will have to recognize and navigate in order to successfully commercialize their products. With a broad focus spanning multiple disease states (oncology, dermatology, inflammatory disorders, among others) attendees will have the opportunity to hear the leading companies discuss the work they have underway and how they are meeting these challenges head-on to apply recent discoveries to a variety of disease processes, restoration of health and improved outcomes.


Download a Brochure                  Join Our Mailing List


Why Attend?

  • Partnering Software & Meetings

  • Easily schedule meetings with our partnering system in order to maximize your time at the event. Schedule one-to-one meetings in advance and stay connected after the event.
  • Industry-Leading Speaking Faculty

  • Our tightly curated content provides tangible and useful insights to how your peers are addressing their scientific, clinical and commercial approach to the space.
  • Network With Industry Colleagues

  • One-to-One meeting space, breakfasts, extended breaks, luncheons and receptions provide attendees with multiple opportunities to connect with colleagues in the space.
  • 20+ Exhibitors/Service Providers

  • Meet with and/or re-connect with exhibitors and service providers and learn about the latest tools and resources driving the field of microbiome science.

Nutrition Track Agenda Announced for 4th Annual Translational Microbiome Conference

Nutrition track focuses on development of nutrition-based treatments and regulatory challenges related to medical food

MINNEAPOLIS, March 29, 2018– Arrowhead Publishers released a parallel nutrition track agenda for the 4th Annual Translational Microbiome Conference, scheduled April 18-20 in Boston. The conference is designed to bring together scientists at the forefront of microbiome research with pioneering business leaders at companies generating microbiome-based medical solutions. Sponsored by Nestlé Health Science, the nutrition track focuses on issues and learnings around development of medical food, with specific examples of innovative nutritional treatments for IBD and obesity. The focused sessions will cover current regulatory criteria for medical food, as well as common regulatory challenges faced by companies innovating in nutrition science.
“Nutrition science is advancing at such a rapid rate, and regulation is complex and dynamic,” said John Waslif, Managing Director of Arrowhead Publishers. “We designed the nutrition track at our 4th Annual Translational Microbiome Conference as a forum for thought leaders to share best practices and insights, because collaboration in this environment can help speed development and clear hurdles.”
A growing body of research showcases the role nutritional solutions can play in prevention and treatment of many common issues, and nutrition track sessions are developed to provide translational insight to other companies navigating that path.
Nutrition track sessions include:

Eating for Two: Developing Nutritional Interventions and Naturally Derived Products that Consider Host and Microbial Requirements for Improved Human Health
Paul Giannasca, Ph.D., Global Scientific Lead, GI Health, Nestlé Health Science
The design of new nutritional measures and therapies will be advanced through an integrated approach incorporating knowledge of host nutrition, GI biology, our bacterial symbionts and the many intersecting metabolic pathways. The presentation will summarize ongoing efforts to develop nutritional interventions for IBD, the use of traditional Chinese botanicals to develop drugs for GI health and the mining of bacterial culture collections for beneficial strains.

Diet, the Gut Microbiome, and its Metabolome in Inflammatory Bowel Disease: Therapeutic Opportunities
Elliot Friedman, Ph.D., Senior Research Investigator, Division of Gastroenterology, Technical Director, Microbial Culture & Metabolomics Core, PennCHOP Microbiome Program, Perelman School of Medicine, University of Pennsylvania
The environment of the gut, namely the microbiota and diet, plays an important role in the pathogenesis of the inflammatory bowel diseases (IBD) that afflict approximately 3 million patients in the U.S. alone. Characterization of the impact of diet on both the composition of the gut microbiota as well as the metabolites that are produced might lead to the discovery of alternative strategies to treat IBD by engineering the environment of the gut. Using defined formula diets as a therapeutic probe, we describe several human subject studies that are designed to help determine better diets for patients with IBD that can be used to treat and/or prevent the recurrence of active disease.

Nutritional Approaches that impact the microbiome: Hype, Hope, and Regulatory Realities of Medical Foods
Tim Morck, Ph.D., President, Spectrum Nutrition
When research shows an impact of a product on the microbiome, with positive outcomes on certain markers of health or disease, what regulatory category does it fall under for commercialization, and what claims are permissible? This presentation will explain current regulatory criteria for medical food, and share encouraging steps being taken to address the challenges regulators face to keep pace with rapidly advancing nutritional science.

Panel Discussion: Microbiome Products as Medical Foods: Is There a Nutritional Requirement for Bacteria?
Moderated by Bernadette Janas, Ph.D., Global Medical Affairs Lead, Nestlé Health Science
David Beno, Ph.D., Chief Scientific Officer, Xeno Biosciences
Colleen Cutcliffe, Ph.D., Chief Executive Officer, Whole Biome
Tim Morck, Ph.D., President, Spectrum Nutrition
This panel session will explore questions such as these:
- Is the data sufficient to establish an "ideal" microbiome composition to support health, that might permit supplemental bacteria to be considered similar to an "essential nutrient" to correct an imbalance associated with a disease?
- Is lack of enforcement by the FDA toward companies marketing supplements as medical foods in the space indicative of their stance?
- Does the FDA have the resources to address this issue and how will companies in the space be able to successfully elevate the priority of this issue to a level where the FDA commits to take action to clarify this area?
- How should companies conduct a risk/benefit analysis when considering launching a new product in an uncertain regulatory space?

Pharmacological Mimicry of Gastric Bypass Microbiome to Treat Obesity
David Beno, Ph.D., Chief Scientific Officer, Xeno Biosciences
Xeno Biosciences is leveraging nascent bariatric surgery/microbiome science to develop XEN-101. We have proposed the "air hypothesis" as a mechanism to explain the profound weight loss and the associated microbiome shifts observed after gastric bypass surgery. We created XEN-101, a first-in-class, oral anti-obesity medicine. XEN-101 has preclinical and initial clinical pilot efficacy data, demonstrating substantial weight loss and corresponding shifts in the gut microbiome. Xeno is currently in early development preparing for Phase I studies.

View the full agenda for the 4th Annual Translational Microbiome Conference at
Sponsors and Exhibitors can showcase products and branding in an environment designed to facilitate professional networking. Learn more via
# # #
Arrowhead Publishers brings life sciences industry professionals together to help move research forward through learning, networking and professional growth. Arrowhead focuses on offering thoughtfully curated speakers, new research industry trends, case studies, emerging discoveries and the future focus of the biotech and pharmaceutical industries. Arrowhead conferences cover clinical development and cutting-edge research, regulatory issues and market dynamics, therapeutics, drug discovery and positioning, and emerging technologies for both clinicians and pharmaceutical professionals.

If you would like more information about this announcement or the 4th Annual Translational Microbiome Conference, please contact John Waslif, Managing Director at Arrowhead Publishers via email at This email address is being protected from spambots. You need JavaScript enabled to view it..


Great conference, high-quality talks. Congrats on organizing such an event!

Conference Attendee
Computational Biologist , Memorial Sloan Kettering Cancer Center

It was a fantastic conference, and I truly got a lot out of hearing from and speaking with the diverse range of speakers and attendees. It’s really a great event and I’m glad to have been a part... Read More

Elliot Friedman
Technical Director, PennCHOP Microbiome Program , University of Pennsylvania

An excellent meeting where the excitement and challenges in microbiome research are presented. Well balanced in translational microbiome research, ethical issues, and investment opportunities and... Read More

Seyoum Ayehunie
VP of Immunological Systems , Mattek

A great diversity of subjects and depths were covered so both experts and new-comers had sessions they could gain insights from. The mix of subjects brings the field together and helps build the... Read More

Dale Pfost
CEO , Microbiome Therapeutics

This is an excellent conference to get updated in the field and at the same time connect with other players in this exciting field.

Morten Isaksen
CEO , Bio-Me

It’s the perfect blend of science and industry. A diverse and amazing group of people in one of the fastest-growing and most promising fields.

Stephen Skolnick
Founder , Mood Nutraceuticals

This is my third year attending the conference and it gets better every year. The diverse topics, great speakers, with latest research findings and targeted workshops and panel discussion. Would... Read More

Ying Chen
Research & Development Manager , Reckitt Benckiser

My second experience with such a meeting, but night and day difference! Very informative and of high standard

Pinaki Panigrahi
Professor , University of Nebraska Medical Center

An excellent meeting where the excitement and challenges in microbiome research are presented. Well balanced in translational microbiome research, ethical issues, and investment opportunities and... Read More

Seyoum Ayehunie
Vice President of Immunological Systems , Mattek

Great mix of microbiomics science, pharmaceutical development and networking

Tarik Alhmaud
Physician , University of New Mexico

For someone with a nascent interest in the microbiome, this conference has been an extremely transformative experience

Dalton Price
Founder and Executive Director , YouResearch

Very well organized and focused group

Gerardo Toledo

The conference was educational both in terms of exposing me to the current microbiome-related science as well as the several aspects of running a business in this field

Sneha Jani
Ph.D. Student , Texas A&M University

Overall, it was a great conference. As a student, some of the business discussions were above my head, but I had a really great experience

Anand Kumar
PostDoc , Los Alamos National Lab

I'm a Research Associate at a startup and was able to gather lots of information that will inform establishment of our NGS core

Conference Attendee

A great immersion into the microbiome space with competent speakers and engaging attendees

Conference Attendee

Good mix of topics and speakers

Conference Attendee

Broad spectrum, background for profound understanding

Conference Attendee

Liked the diversity of presenters and attendees, presentation length was good and well-run

Conference Attendee

Really appreciated the equity and range in gender, expertise, and age of speakers

Conference Attendee

Great representation of topics and perspectives

Conference Attendee

Developed a number of new relationships

Conference Attendee

Diverse audience and speakers—scientist and business aspects

Conference Attendee

Very informative and exciting conference, learned a lot and fostered new ideas. Really glad I came!

Conference Attendee

Great panel, great speakers, crowd was ideal size

Conference Attendee


The Westin Copley Place
10 Huntington Avenue
Boston, MA 02116 USA
Phone: 617-262-9600

A guest room block will be available for attendees, exhibitors and speakers. More information coming soon.


Who Should Attend


Academic Institutions, Bioscience Companies, Pharma Companies, Diagnostics Companies and Investors

Job Titles:

VPs, Directors, Heads, Scientists, Professors in following areas: 

  • Microbiome / Microbiota basic research

  • NGS (Next Generation Sequencing)

  • Molecular Diagnostics

  • Autoimmune Disease Therapeutics

  • Infectious Diseases

  • Metabolic disease, Obesity, Diabetes

  • Genotyping

  • Genomics

  • Genomic Profiling

  • Biomarkers

  • Immunology Innate or Adaptive Immunity

  • Bioinformatics

  • Data Management

  • Data Analysis

  • Molecular Biology

  • Diagnostic & Clinical Applications

  • Prenantal Diagnostics

  • Vaccines

  • Microbiology

  • Food / Nutrition Science

  • Gut-Brain Axis Researchers

  • Venture Capitalists

  • Biotech Entrepreneurs

  • Academic Licensing or Tech Transfer Officers

  • Business Development / In-Licensing

  • FDA regulation

  • Clinical trials

  • Epigenetics

  • Metagenomics

  • High-Throughput Technologies

  • Data Analysis

  • Data Storage

  • Cloud Computing

  • Statistical Genomics

About Us

Our events give attendees a conference experience that encompasses learning, networking and professional growth. We strive to facilitate connections. At our events, attendees, speakers, sponsors and exhibitors have opportunities to network and then to utilize those connections to further their professional goals. At Arrowhead Publishers, our focus is on bringing life sciences industry professionals together to help move research forward. Learn more about us at

Contact Us

Arrowhead Publishers & Conferences
PO Box 96
7730 Laredo Drive, #96
Chanhassen, MN 55317


Download the Post-Event Report

April 16-18, 2019 | Boston, MA USA

Interesting Image
Post-Event Report
Read our Privacy Policy and Terms and Conditions
We'd like to keep you informed about this conference by sending you an occasional email regarding the agenda, speaker additions, conference discounts and other details relevant to this conference. We never share your data with anyone, EVER!